Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #5143 on Halozyme Therapeutics Inc (HALO)
XenaLives
02/03/17 2:50 PM
#5144 RE: maumar #5143
As of the date of this Statement, the Reporting Persons beneficially owned in the aggregate 18,426,928 shares of Common Stock which equates to approximately 14.2% of the outstanding shares (the percentage of shares of Common Stock owned being based upon 129,490.070 shares of Common Stock outstanding at November 1, 2016 as set forth in the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2016).